The impact of a best practice advisory on inpatient prescribing of piperacillin-tazobactam

被引：0
|
作者：
Peterson, Katherine L. [1 ]
Tompkins, Bradley J. [2 ]
Ahern, John W. [3 ]
Smith, Lindsay M. [1 ]
机构：
[1] Univ Vermont Med Ctr, Div Infect Dis, 111 Colchester Ave, Burlington, VT 05401 USA
[2] Univ Vermont, Dept Med, Larner Coll Med, Burlington, VT USA
[3] Univ Vermont Med Ctr, Dept Pharm, Burlington, VT USA
来源：
ANTIMICROBIAL STEWARDSHIP & HEALTHCARE EPIDEMIOLOGY | 2022年 / 2卷 / 01期
关键词：
INFECTIOUS-DISEASES SOCIETY; HEALTH-CARE EPIDEMIOLOGY; STEWARDSHIP; PROGRAM; AMERICA; GUIDELINES;
D O I：
10.1017/ash.2022.12
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
[No abstract available]
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Reevaluating Piperacillin-Tazobactam Mortality-Reply
    Chanderraj, Rishi
    Dickson, Robert P.
    Sjoding, Michael W.
    JAMA INTERNAL MEDICINE, 2024, 184 (10) : 1269 - 1269
  • [22] Piperacillin-Tazobactam Penetration into Human Pancreatic Juice
    Minelli, Elisa Bertazzoni
    Benini, Anna
    Franco, Luigina
    Bassi, Claudio
    Pederzoli, Paolo
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2008, 52 (11) : 4149 - 4152
  • [23] Fixed Drug Eruption Caused by Piperacillin-Tazobactam
    Santosa, A.
    Teo, B. W.
    Shek, L. P-C
    JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY, 2013, 23 (02) : 132 - 133
  • [24] A CASE REPORT ON PIPERACILLIN-TAZOBACTAM INDUCED TRANSAMINITIS
    Joseph, Aida Mary
    Mathew, Elza
    Shaji, Jeethu K.
    Prakash, Aleena
    Menaka, K.
    Sivakumar, T.
    INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2018, 5 (10): : 9761 - 9763
  • [25] EFFECT OF PIPERACILLIN-TAZOBACTAM THERAPY ON INTESTINAL MICROFLORA
    NORD, CE
    BRISMAR, B
    KASHOLMTENGVE, B
    TUNEVALL, G
    SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 1992, 24 (02) : 209 - 213
  • [26] PIPERACILLIN-TAZOBACTAM PHARMACOKINETICS IN PATIENTS WITH INTRAABDOMINAL INFECTIONS
    JHEE, SS
    KERN, JW
    BURM, JP
    YELLIN, AE
    GILL, MA
    PHARMACOTHERAPY, 1995, 15 (04): : 472 - 478
  • [27] Impact of extended-infusion piperacillin-tazobactam in a Canadian community hospital
    Chan, April J.
    Lebovic, Gerald
    Wan, Michael
    Chen, Yan
    Leung, Elizabeth
    Langford, Bradley J.
    Seah, Jenny
    Taggart, Linda R.
    Downing, Mark
    INFECTIOUS MEDICINE, 2023, 2 (01): : 31 - 35
  • [28] Vancomycin/Piperacillin-tazobactam Nephrotoxicity in the Critically Ill
    Kollef, Marin H.
    Juang, Paul
    Micek, Scott T.
    CLINICAL INFECTIOUS DISEASES, 2020, 70 (07) : 1520 - 1521
  • [29] Rationale and evidence for extended infusion of piperacillin-tazobactam
    Kaufman, Scott E.
    Donnell, Robert W.
    Hickey, W. Scott
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2011, 68 (16) : 1521 - 1526
  • [30] Piperacillin-tazobactam as alternative to carbapenems for ICU patients
    Pilmis, Benoit
    Jullien, Vincent
    Tabah, Alexis
    Zahar, Jean-Ralph
    Brun-Buisson, Christian
    ANNALS OF INTENSIVE CARE, 2017, 7
12345